Development of carboxylic acid replacements in indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase

Bioorg Med Chem Lett. 2007 Sep 15;17(18):5143-9. doi: 10.1016/j.bmcl.2007.06.093. Epub 2007 Jul 7.

Abstract

Allosteric inhibition of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase enzyme has recently emerged as a viable strategy toward blocking replication of viral RNA in cell-based systems. We report here 2 series of indole-N-acetamides, bearing physicochemically diverse carboxylic acid replacements, which show potent affinity for the NS5B enzyme with reduced potential for formation of glucuronide conjugates. Preliminary optimization of these series furnished compounds that are potent in the blockade of subgenomic HCV RNA replication in HUH-7 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carboxylic Acids / chemistry*
  • Cell Line
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Indoleacetic Acids / chemistry*
  • Indoleacetic Acids / pharmacology*
  • Viral Nonstructural Proteins / antagonists & inhibitors*

Substances

  • Carboxylic Acids
  • Enzyme Inhibitors
  • Indoleacetic Acids
  • Viral Nonstructural Proteins
  • indoleacetamide
  • NS-5 protein, hepatitis C virus